-
B Cell Immune Repertoire Sequencing Identifies Pre-Transplant Rejection Risk
-
B Cell Reconstitution: 36-Month Analysis of Patients Post-Alemtuzumab Induction Followed by Belatacept-Based Immunosuppression
-
B-Cell Depletion with Rituximab Exacerbates Anti-Donor CD4+ T-Cell Responses in Patients with Donor-Specific Anti-Human Leukocyte Antigen Antibodies
-
Bacterial Complications in Liver Transplant Recipients Undergoing Biliary Tract Manipulation: Effect of an Antibiotic Prophylaxis Protocol
-
Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for the Treatment of Medically Refractory Hepatic Encephalopathy (HE) in Patients with ESLD and Significant Portal-Venous Shunting
-
Bariatric Surgery before and after Kidney Transplantation: Long-Term Weight-Loss and Allograft Outcomes
-
Barriers and Disparities in Listing for Pediatric Solid Organ Transplant
-
Basiliximab Induction in HIV-Positive Renal Transplant Recipients Compared to an HIV-Negative Cohort
-
Basiliximab Induction in Simultaneous Liver-Kidney Transplant
-
Belatacept and Tacrolimus Corticosteroid-Free Regimens Lead to Elevated Mycophenolic Acid Exposure at 1 and 3 Months after Kidney Transplantation
-
Belatacept in Kidney Transplant Recipients with Preformed Donor Specific Anti-HLA Antibodies: Results of the BELACOR Trial
-
Belatacept Maintenance Immunosuppression Use and Outcomes in the Real-World Clinical Setting Using OPTN/UNOS Kidney Transplant Registry
-
Belatacept-Refractory CD8+CD28–CD38hi Effector/Memory T Cells Are Targeted by mTOR Inhibition Leading to a Preferential Loss of CD40L
-
Benefit of Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy Compared to HBIG Combined with Entecavir in Long Term Renal Function
-
Benefit of Patient Portal Usage in Non-High Risk Kidney Transplant Recipients
-
BETA-2 Score is an Excellent Tool for Monitoring of Islet Allograft Function and Early Detection of Transplant Dysfunction
-
Biliary pH, Bicarbonate and Glucose Are Suitable Biomarkers of Bile Duct Viability during Normothermic Machine Perfusion of Human Donor Livers
-
Biochemistry Profiles Following Pig-to-Nonhuman Primate Liver Xenotransplantation
-
Bioinformatics Approach to the Development of a Novel Molecular Biomarker for Sub-Clinical Acute Rejection (subAR) in the Peripheral Blood Following Kidney Transplant (KT)
-
Biomaterial-Based Localized and Controlled Delivery of Tofacitinib to Actuate Enhanced Costimulation Blockade and Promote Long-Term Transplant Survival
-
Biopsy Correlates of DSA in Antibody-Mediated Rejection: C4d vs Microvascular Inflammation Scores
-
BK Nephropathy in Non-Kidney Transplant Patients, a Case Series and Systematic Review of the Literature
-
BK Polyomavirus (BKPyV)-Specific T Cells as a Diagnostic and Prognostic Marker for BKPyV-Infections after Pediatric Kidney Transplantation
-
BK Viremia in Simultaneous Kidney Pancreas Recipients: Single Center Experience
-
Blood Transfusion is a Critical Determinant of Resource Utilization and Total Hospital Cost in Liver Transplantation
-
Bloodstream Infection Caused by Enteric Organisms during the First 6 Months after Intestinal Transplant
-
BLyS-/- Rats to Prevent Alloantibody Production
-
Bone Marrow Derived Myeloid Suppressor Cell (BM-MDSCs) Prolongs the Graft Survival in Murine Heart Transplantation
-
Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection – A Double-Blind Randomized Placebo-Controlled Trial (BORTEJECT Study)
-
Brain Death Conditions Intensify Inflammation and Impair Metabolic Gene Expression
-
Brincidofovir for Disseminated Adenovirus in Kidney and Kidney-Pancreas Transplant Recipients: Report of a Case Series
-
Brincidofovir Was Used to Successfully Treat Adenovirus Infections in Solid Organ Transplant Recipients and Other Immunocompromised Patients
-
Broader Geographic Sharing and Impact on Lung Transplant Waitlist Time and Lung Allocation Score
-
Building a Third-Party VST Bank from Scratch- The Cincinnati Experience
-
Burden of Infectious Complications after Upper Extremity Allotransplantation: A Matched Cohort Study
-
Burden of Primary CMV Infections Remains High Despite Six Months Valganciclovir Prophylaxis in High-Risk Kidney Transplant Recipients
2018 American Transplant Congress
June 2-6, 2018 in Seattle, WA